Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement

Heart

Volumn 101, Issue 17, 2015, Pages 1382-1388

  Lindman, Brian R ^a   Breyley, Jared G ^a   Schilling, Joel D ^a   Vatterott, Anna M ^a   Zajarias, Alan ^a   Maniar, Hersh S ^a   Damiano, Ralph J ^a   Moon, Marc R ^a   Lawton, Jennifer S ^a   Gage, Brian F ^a   Sintek, Marc A ^a   Aquino, Alejandro ^a   Holley, Christopher L ^a   Patel, Neil M ^a   Lawler, Cassandra ^a   Lasala, John M ^a   Novak, Eric ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; GALECTIN 3; GROWTH DIFFERENTIATION FACTOR 15; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; PEPTIDES AND PROTEINS; ST2 PROTEIN; TROPONIN T; UNCLASSIFIED DRUG; BRAIN NATRIURETIC PEPTIDE; CELL SURFACE RECEPTOR; GDF15 PROTEIN, HUMAN; IL1RL1 PROTEIN, HUMAN; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

AGED; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART MUSCLE FIBROSIS; HEART STRESS; HIGH RISK PATIENT; HUMAN; INTERMEDIATE RISK PATIENT; MAJOR CLINICAL STUDY; MALE; MYOCARDITIS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SURGICAL RISK; SURVIVAL TIME; ADVERSE EFFECTS; AORTIC VALVE STENOSIS; BLOOD; HEART CATHETERIZATION; HEART VALVE REPLACEMENT; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; BIOMARKERS; CARDIAC CATHETERIZATION; FEMALE; GROWTH DIFFERENTIATION FACTOR 15; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECEPTORS, CELL SURFACE; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STRESS, PHYSIOLOGICAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 84941652613     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2015-307742     Document Type: Article

References (23)

1. Otto CM, Prendergast B. Aortic-valve stenosis-from patients at risk to severe valve obstruction. N Engl J Med 2014;371:744-56.
2. Lindman BR, Bonow RO, Otto CM. Current management of calcific aortic stenosis. Circ Res 2013;113:223-37.
3. Bergler-Klein J, Klaar U, Heger M, et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 2004;109:2302-8.
4. Chin CW, Shah AS, McAllister DA, et al. High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis. Eur Heart J 2014;35:2312-21.
5. Ky B, French B, Levy WC, et al. Multiple biomarkers for risk prediction in chronic heart failure. Circ Heart Fail 2012;5:183-90.
6. Kempf T, Von Haehling S, Peter T, et al. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. J Am Coll Cardiol 2007;50:1054-60.
7. Ky B, French B, McCloskey K, et al. High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure. Circ Heart Fail 2011;4:180-7.
8. Bettencourt P, Azevedo A, Pimenta J, et al. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 2004;110:2168-74.
9. Braunwald E. Biomarkers in heart failure. N Engl J Med 2008;358:2148-59.
10. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;129:e521-643.
11. Baumgartner H, Hung J, Bermejo J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr 2009;10:1-25.
12. Lindman BR, Arnold SV, Madrazo JA, et al. The adverse impact of diabetes mellitus on left ventricular remodeling and function in patients with severe aortic stenosis. Circ Heart Fail 2011;4:286-92.
13. Harrell FE Jr. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York, NY: Springer-Verlag, 2010.
14. Pencina MJ, D'Agostino RB, Sr, D'Agostino RB, Jr, et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-72.
15. Pencina MJ, D'Agostino RB, Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011;30:11-21.
16. Vahanian A, Alfieri O, Andreotti F, et al., Joint Task Force on the Management of Valvular Heart Disease of the European Society of C, European Association for Cardio-Thoracic S. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012;33:2451-96.
17. Dweck MR, Joshi S, Murigu T, et al. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol 2011;58:1271-9.
18. Wang TJ, Wollert KC, Larson MG, et al. Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study. Circulation 2012;126:1596-604.
19. Lindman BR, Alexander KP, O'Gara PT, et al. Futility, Benefit, and Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv 2014;7:707-16.
20. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187-98.
21. Adams DH, Popma JJ, Reardon MJ, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 2014;370:1790-8.
22. O'Brien SM, Shahian DM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2-isolated valve surgery. Ann Thorac Surg 2009;88:S23-42.
23. Dewey TM, Brown D, Ryan WH, et al. Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg 2008;135:180-7.